Suchergebnisse - "Menter, Alan"

PubPharm (27)

1

Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study

enthalten in: American journal of clinical dermatology | 2019

von Lebwohl, M. | Blauvelt, A. | Menter, A. | +5

2

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

enthalten in: Journal of the American Academy of Dermatology | 2019

von Menter, A. | Strober, B. | Kaplan, D. | +29

CommentIn: J Am Acad Dermatol. 2019 Aug;81(2):e45. - PMID 30930086

3

Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis : a review of the literature

enthalten in: Therapeutic delivery | 2017

von Frieder, J. | Kivelevitch, D. | Menter, A.

4

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis : Sub-Group Analysis of the PSO-ABLE Study

enthalten in: American journal of clinical dermatology | 2017

von Paul, C. | Leonardi, C. | Menter, A. | +5

ErratumIn: Am J Clin Dermatol. 2017 May 24;:. - PMID 28540589

5

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

enthalten in: The New England journal of medicine | 2017

von Papp, K. | Blauvelt, A. | Bukhalo, M. | +14

6

Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in a Psoriasis Patient Treated With Ustekinumab

enthalten in: Journal of drugs in dermatology : JDD | 2017

von Dickson, L. | Menter, A.

7

A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies

enthalten in: Expert opinion on investigational drugs | 2016

von Campa, M. | Menter, A.

8

The spectrum of nephrocutaneous diseases and associations : Inflammatory and medication-related nephrocutaneous associations

enthalten in: Journal of the American Academy of Dermatology | 2016

von Pascoe, V. | Fenves, A. | Wofford, J. | +3

9

Tumor Necrosis Factor-α Inhibitor Use in Psoriasis Patients With a First-degree Relative With Multiple Sclerosis

enthalten in: Journal of drugs in dermatology : JDD | 2015

von Mansouri, B. | Horner, M. | Menter, A.

10

Emerging oral drugs for psoriasis

enthalten in: Expert opinion on emerging drugs | 2015

von Mahmood, T. | Zaghi, D. | Menter, A.